Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,274,213 papers from all fields of science
Search
Sign In
Create Free Account
Antipsychotic Agents
Known as:
Agents, Major Tranquillizing
, Neuroleptics
, Tranquilizers, Major
Expand
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
1 ML haloperidol decanoate 100 MG/ML Injection
1.6 ML aripiprazole lauroxil 276 MG/ML Prefilled Syringe
Antipsychotics:PrThr:Pt:Urine:Ord:Screen
Antipsychotics:Prid:Pt:Urine:Nom
Expand
Narrower (28)
Acepromazine
Azaperone
Butaclamol
Chlorprothixene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Diagnostic and Statistical Manual of Mental Disorders
Janet B. W. Williams
2013
Corpus ID: 43900901
Given the recent attention to movement abnormalities in psychosis spectrum disorders (e.g
Review
2010
Review
2010
International consensus study of antipsychotic dosing.
D. Gardner
,
A. Murphy
,
Heather O'Donnell
,
F. Centorrino
,
R. Baldessarini
American Journal of Psychiatry
2010
Corpus ID: 7658920
OBJECTIVE Potency equivalents for anti-psychotic drugs are required to guide clinical dosing and for designing and interpreting…
Expand
Highly Cited
2005
Highly Cited
2005
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
J. Lieberman
,
T. Stroup
,
+10 authors
J. Hsiao
New England Journal of Medicine
2005
Corpus ID: 22499842
BACKGROUND The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents…
Expand
Review
2005
Review
2005
Diagnosis and management of dementia with Lewy bodies
I. McKeith
,
I. McKeith
,
+43 authors
Masahito Yamada
Neurology
2005
Corpus ID: 14354793
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB…
Expand
Review
2005
Review
2005
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
J. Newcomer
CNS Drugs
2005
Corpus ID: 36435377
Increasing numbers of reports concerning diabetes, ketoacidosis, hyperglycaemia and lipid dysregulation in patients treated with…
Expand
Review
1999
Review
1999
Antipsychotic-induced weight gain: a comprehensive research synthesis.
D. B. Allison
,
Janet L. Mentore
,
+4 authors
P. Weiden
American Journal of Psychiatry
1999
Corpus ID: 38635470
OBJECTIVE The purpose of this study was to estimate and compare the effects of antipsychotics-both the newer ones and the…
Expand
Highly Cited
1990
Highly Cited
1990
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
P. Sokoloff
,
B. Giros
,
M. Martres
,
M. Bouthenet
,
J. Schwartz
Nature
1990
Corpus ID: 4284114
A dopamine receptor has been characterized which differs in its pharmacology and signalling system from the D1 or D2 receptor and…
Expand
Highly Cited
1988
Highly Cited
1988
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
G. Dichiara
,
A. Imperato
Proceedings of the National Academy of Sciences…
1988
Corpus ID: 10433223
The effect of various drugs on the extracellular concentration of dopamine in two terminal dopaminergic areas, the nucleus…
Expand
Highly Cited
1988
Highly Cited
1988
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
J. Kane
,
G. Honigfeld
,
J. Singer
,
H. Meltzer
Archives of General Psychiatry
1988
Corpus ID: 20625485
The treatment of schizophrenic patients who fail to respond to adequate trials of neuroleptics is a major challenge. Clozapine…
Expand
Highly Cited
1970
Highly Cited
1970
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
G. Simpson
,
M. B.
,
G. B.
,
J. Angus
,
F. P
,
D. P. M.
Acta Psychiatrica Scandinavica Supplementum
1970
Corpus ID: 40086127
A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE